Patients with type 2 diabetes who have poor glycemic control and a certain genetic variation have an increased risk of coronary artery disease, according to a new study.
Read More »Genetic Testing No Help in Predicting Type 2 Diabetes
Traditional risk factors, such as obesity, are just as useful, studies find
Read More »Garlic Treats Diabetes I And II, Study Suggests
A new study says A drug based on a chemical found in garlic can treat diabetes types I and II when taken as a tablet.
Read More »Groundbreaking Data On the Impact of Prediabetes
Consumer Health Sciences, findings demonstrated a significant impact of having prediabetes on the quality of life and work productivity of patients.
Read More »Cost of Diabetes Rises to $218 Billion a Year
From just a year ago, the cost for diabetes was $173 billion. For 2007 the cost as risen to $218 billion US dollars. A new study, puts the total at $218 billion last year- the first comprehensive estimate of the financial toll diabetes takes.
Read More »Assessment Tool Helps Screen Patients for Prediabetes
An assessment tool known as Tool to Assess Likelihood of Fasting Glucose ImpairmenT (TAG-IT) is effective in screening patients of varying ethnic backgrounds for prediabetes, according to the results of a new study. Researchers say the test is an improvement over using BMI alone or using a list of risk …
Read More »Rosuvastatin Reduces Cardiac Events in “Healthy” Patients With High CRP
Treatment with cholesterol-lowering rosuvastatin reduced coronary events by 44% — including overall mortality — among patients who are asymptomatic for heart disease but have high levels of high-sensitivity C-reactive protein and low levels of low-density lipoprotein (LDL) cholesterol.
Read More »U.S. Heart Failure Doubles Over 25 Years, Study Finds
Twice as many older Americans are hospitalized with heart failure than 25 years ago, reflecting an aging population and success in keeping people alive after heart attacks and disease damage the organ, researchers said.
Read More »High- Sensitivity CRP Enhances Risk Prediction for Heart Disease
High-sensitivity C-reactive protein modestly improves prediction of global cardiovascular risk beyond traditional risk factors, according to two longitudinal studies.
Read More »Generex Launches Oral Insulin for Diabetes Management
Generex announces a partnership with a company to promote their oral insulin with more than a 1000 person sales force in India.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.